Gastroenterology
Volume 129, Issue 6 , Pages 1825-1831, December 2005

Prevalence of Barrett’s Esophagus in the General Population: An Endoscopic Study

  • Jukka Ronkainen

      Affiliations

    • Centre for Family Medicine, Karolinska Institutet, Stockholm, Sweden
    • Primary Health Care Center, Keminmaa, Finland
    • Corresponding Author InformationAddress requests for reprints to: Jukka Ronkainen, MD, Primary Health Care Center, Väylätie 2, Keminmaa SF-94400, Finland. fax: (358) 16-227165.
  • ,
  • Pertti Aro

      Affiliations

    • Centre for Family Medicine, Karolinska Institutet, Stockholm, Sweden
  • ,
  • Tom Storskrubb

      Affiliations

    • Centre for Family Medicine, Karolinska Institutet, Stockholm, Sweden
    • Department of Medicine, Kalix Hospital, Kalix, Sweden
  • ,
  • Sven–Erik Johansson

      Affiliations

    • Centre for Family Medicine, Karolinska Institutet, Stockholm, Sweden
  • ,
  • Tore Lind

      Affiliations

    • AstraZeneca R&D, Mölndal, Sweden
  • ,
  • Elisabeth Bolling–Sternevald

      Affiliations

    • Centre for Family Medicine, Karolinska Institutet, Stockholm, Sweden
    • AstraZeneca R&D, Mölndal, Sweden
  • ,
  • Michael Vieth

      Affiliations

    • Institute of Pathology, Bayreuth, Germany
  • ,
  • Manfred Stolte

      Affiliations

    • Institute of Pathology, Bayreuth, Germany
  • ,
  • Nicholas J. Talley

      Affiliations

    • Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota
    • Department of Medicine, University of Sydney, Sydney, Australia
  • ,
  • Lars Agréus

      Affiliations

    • Centre for Family Medicine, Karolinska Institutet, Stockholm, Sweden

Received 5 May 2005; accepted 17 August 2005. published online 04 October 2005.

Background & Aims: Barrett’s esophagus (BE) is associated with esophageal adenocarcinoma, the incidence of which has been increasing dramatically. The prevalence of BE in the general population is uncertain because upper endoscopy is required for diagnosis. This study aimed to determine the prevalence of BE and possible associated risk factors in an adult Swedish population. Methods: A random sample (n = 3000) of the adult population (n = 21,610) in 2 municipalities was surveyed using a validated gastrointestinal symptom questionnaire (response rate, 74%); a random subsample (n = 1000; mean age, 53.5 years; 51% female) underwent upper endoscopy. Endoscopic signs suggestive of columnar-lined esophagus (CLE) were defined as mucosal tongues or an upward shift of the squamocolumnar junction. BE was diagnosed when specialized intestinal metaplasia was detected histologically in suspected CLE. Results: BE was present in 16 subjects (1.6%; 95% confidence interval, 0.8–2.4): 5 with a long segment and 11 with a short segment. Overall, 40% reported reflux symptoms and 15.5% showed esophagitis; 103 (10%) had suspected CLE, and 12 (1.2%) had a visible segment ≥2 cm. The prevalence of BE in those with reflux symptoms was 2.3% and in those without reflux symptoms was 1.2% (P = .18). In those with esophagitis, the prevalence was 2.6%; in those without, the prevalence was 1.4% (P = .32). Alcohol (P = .04) and smoking (P = .047) were independent risk factors for BE. Conclusions: BE was found in 1.6% of the general Swedish population. Alcohol and smoking were significant risk factors.

Abbreviations used in this paper:  BE, Barrett’s esophagus , CI, confidence interval , CLE, columnar-lined esophagus , EGD, esophagogastroduodenoscopy , LSBE, long-segment Barrett’s esophagus , OR, odds ratio , SIM, specialized intestinal metaplasia , SSBE, short-segment Barrett’s esophagus

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by the Swedish Research Council, the Swedish Society of Medicine, Mag-tarm sjukas förbund, Norrbotten County Council (Sweden), and AstraZeneca R&D (Sweden).

PII: S0016-5085(05)01771-3

doi:10.1053/j.gastro.2005.08.053

Refers to article:

  • A Population Prevalence of Barrett’s Esophagus—Finally

    Richard E. Sampliner
    Gastroenterology December 2005 (Vol. 129, Issue 6, Pages 2101-2103)

Gastroenterology
Volume 129, Issue 6 , Pages 1825-1831, December 2005